Sofosbuvir Completed Phase 3 Trials for Human Immunodeficiency Virus (HIV) / Hepatitis C Virus Infection, Response to Therapy of Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03369327Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus